Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.84B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.48B |
| 3 |
Nike
NKE
|
+$1.17B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$922M |
| 5 |
Hewlett Packard
HPE
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$1.14B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.13B |
| 3 |
Broadcom
AVGO
|
+$625M |
| 4 |
UnitedHealth
UNH
|
+$584M |
| 5 |
Mastercard
MA
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.22% |
| 2 | Financials | 9.75% |
| 3 | Consumer Discretionary | 7.43% |
| 4 | Healthcare | 7.41% |
| 5 | Industrials | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5676
BlackRock TCP Capital
TCPC
$300M
| $128K | ﹤0.01% |
16,006
+616
| +4% | +$5.34K |
|
5677
Atossa Therapeutics
ATOS
$23.9M
| $126K | ﹤0.01% |
12,528
-10,463
| -46% | -$127K |
|
5678
Outlook Therapeutics
OTLK
$196M
| $126K | ﹤0.01% |
103,524
+44,063
| +74% | +$77.3K |
|
|
NINE
5679
DELISTED
Nine Energy Service
NINE
| $126K | ﹤0.01% |
111,690
-13,004
| -10% | -$16K |
|
|
ARTV
5680
Artiva Biotherapeutics
ARTV
$579M
| $126K | ﹤0.01% |
41,952
+3,882
| +10% | +$21K |
|
|
OGG
5681
Osisko Gold Group Inc.
OGG
$814M
| $126K | ﹤0.01% |
84,451
-37
| -0% | -$55 |
|
5682
Saga Communications
SGA
$59.8M
| $125K | ﹤0.01% |
10,024
-134
| -1% | -$1.62K |
|
5683
Gyre Therapeutics
GYRE
$705M
| $125K | ﹤0.01% |
16,147
-10,239
| -39% | -$112K |
|
5684
First Northwest Bancorp
FNWB
$107M
| $124K | ﹤0.01% |
12,174
-123
| -1% | -$1.3K |
|
5685
Actinium Pharmaceuticals
ATNM
$23.5M
| $124K | ﹤0.01% |
76,811
-58,485
| -43% | -$74.2K |
|
|
MYD
5686
DELISTED
BlackRock MuniYield Fund
MYD
| $123K | ﹤0.01% |
11,655
| – | – |
|
5687
Noodles & Co
NDLS
$107M
| $121K | ﹤0.01% |
13,833
+10,623
| +331% | +$105K |
|
5688
SES AI
SES
$191M
| $120K | ﹤0.01% |
231,400
-252,629
| -52% | -$232K |
|
5689
Tenaya Therapeutics
TNYA
$173M
| $120K | ﹤0.01% |
211,171
-94,837
| -31% | -$93.6K |
|
5690
Ondas Inc
ONDS
$5.05B
| $120K | ﹤0.01% |
112,373
+91,732
| +444% | +$137K |
|
5691
iShares 25+ Year Treasury STRIPS Bond ETF
GOVZ
$262M
| $120K | ﹤0.01% |
+2,919
| New | +$117K |
|
5692
Prelude Therapeutics
PRLD
$374M
| $119K | ﹤0.01% |
155,215
+6,889
| +5% | +$6.43K |
|
5693
OptimumBank Holdings
OPHC
$107M
| $118K | ﹤0.01% |
28,809
+5,720
| +25% | +$25.6K |
|
5694
BlackRock MuniHoldings Fund
MHD
$605M
| $118K | ﹤0.01% |
+10,036
| New | +$120K |
|
5695
Acrivon Therapeutics
ACRV
$71.1M
| $117K | ﹤0.01% |
57,519
-180,033
| -76% | -$969K |
|
5696
Tilly's
TLYS
$123M
| $117K | ﹤0.01% |
53,013
-15,642
| -23% | -$57.5K |
|
|
FT
5697
Franklin Universal Trust
FT
$198M
| $117K | ﹤0.01% |
+15,487
| New | +$116K |
|
5698
CALL
Intellia Therapeutics
NTLA
$1.56B
| $115K | ﹤0.01% |
+16,200
| New | +$164K |
|
|
5699
PUT
Intellia Therapeutics
NTLA
$1.56B
| $115K | ﹤0.01% |
+16,200
| New | +$164K |
|
5700
CPI Aerostructures
CVU
$66.1M
| $115K | ﹤0.01% |
+33,165
| New | +$141K |
|
Similar funds
Goldman Sachs's Q1 2025 Portfolio in Review
As of Q1 2025, Goldman Sachs held 6,539 positions worth $618B, down 2.6% from $634B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs's Q1 2025 filing shows 547 new, 2,373 increased, 2,724 reduced and 514 closed positions. Its largest new stake was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M. The largest sale was TC Energy, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q1 2025 buy was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M.
- Goldman Sachs added most to iShares Russell 2000 ETF in Q1 2025, an estimated $1.84B increase.
- Goldman Sachs's biggest Q1 2025 reduction was TC Energy, cutting an estimated $1.14B.
- Goldman Sachs fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $242M.
- Goldman Sachs's ten largest holdings make up 20% of its $618B portfolio in Q1 2025.
- Goldman Sachs opened 547 new positions and closed 514 in Q1 2025.
- Goldman Sachs's portfolio value fell 2.6% quarter-over-quarter to $618B.
Based on Goldman Sachs's 13F filing for Q1 2025, filed 9 May 2025.